Cancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology
09. Dezember 2024 07:10 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the cancer monoclonal antibodies market size will attain a value of USD 337.92 billion by 2031, with a CAGR of 18.4% over the...
Monoclonal Antibody Combination Therapy
31. Juli 2024 14:22 ET
|
KuicK Research
Delhi, July 31, 2024 (GLOBE NEWSWIRE) -- Monoclonal antibody combination therapy represents a significant advancement in modern medicine, particularly in the treatment of cancer and autoimmune...
Cancer Monoclonal Antibodies Market Size Will Reach to USD 410.95 BN by 2032
04. Juli 2023 10:00 ET
|
Precedence Research
Ottawa, July 04, 2023 (GLOBE NEWSWIRE) -- According to Precedence Research, the cancer monoclonal antibodies market size will rise to USD 292.55 billion by 2030. The global cancer monoclonal...
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2016-2023: Trends, Key Players, Documents and Figures
11. Mai 2023 05:18 ET
|
Research and Markets
Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2016-2023" report has been added to ResearchAndMarkets.com's offering.The Global...
Global Cancer Monoclonal Antibodies Market Anticipated to Garner $106,825.10 Million, Growing at a 7.0% CAGR in the 2022-2031 Timeframe [260-Pages] | Announced by Research Dive
26. April 2023 10:30 ET
|
Research Dive
New York, USA, April 26, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global cancer monoclonal antibodies market. According to the report, the global market is projected...
Cancer Monoclonal Antibodies Market, $106.8 Billion by 2031: Report
20. März 2023 09:57 ET
|
Allied Market Research
Portland, OR, March 20, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global cancer monoclonal antibodies market generated $55.6 billion in 2021, and is...
Precision Cancer Therapeutics Market Research Report 2022: Analysis of Abecma, Breyanzi, Carvykti, Kymriah, Tecartus, Yescarta
22. Dezember 2022 05:43 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Precision Cancer Therapeutics, 2022" report has been added to ResearchAndMarkets.com's offering. The analyst has watched the cancer treatment market...
Conjugated Antibodies in Oncology Analytical Tool 2022: Must-have Reference Tool for Any Business Developer, BI/CI Operative or Clinical Developer
26. Juli 2022 04:48 ET
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Antibodies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Conjugated Antibodies in Oncology:...
Global Cancer Monoclonal Antibody Partnering Deal Terms and Agreements 2015-2022: Latest Agreements in Monoclonal Antibodies, Murine mAb, Chimeric mAb, Humanized mAb, Human aAb
14. Juni 2022 04:33 ET
|
Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Cancer...
Global Cancer Antibodies Drug Conjugate Antibody Market To Reach USD 13 Billion By 2026
23. Oktober 2020 09:55 ET
|
KuicK Research
DELHI, India, Oct. 23, 2020 (GLOBE NEWSWIRE) -- "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: Global Cancer Antibody Drug...